Sternal Closure Systems Market Size & Share 2026 – 2034

Sternal Closure Systems Market Size

The global sternal closure systems market was valued at USD 2.7 billion in 2025 and is projected to exhibit 5.4% CAGR from 2026-2034. The market is expanding as the global volume of cardiac surgery and thoracic surgery continues to rise, driven by the increasing prevalence of cardiovascular diseases, an aging population, and broader access to advanced healthcare services.

For example, heart disease, as estimated by the World Health Organization (WHO), causes 17.9 million deaths every year. Additionally, the Centers for Disease Control and Prevention (CDC) reports that approximately 659,000 U.S. individuals die each year from heart disease, resulting in many cardiac procedures. There are various cardiac operations that call for effective closure methods to create stability after operation and minimize complications. Demand for sternal closure systems is increasing further due to aging populations and widening healthcare access within regions. The mounting disease burden highlights the urgent need for evolved sternal closure systems in cardiac surgery.
 

According to the World Health Organization (WHO), cardiovascular diseases account for approximately 17.9 million deaths annually, while the U.S. Centers for Disease Control and Prevention (CDC) estimates that nearly 659,000 Americans die from heart disease each year, contributing to sustained demand for procedures requiring median sternotomy. As a result, healthcare providers are increasingly adopting advanced sternal closure devices that improve sternal stability, reduce postoperative complications, and support faster patient recovery.

Modern sternal closure systems include stainless steel wires, rigid plate fixation systems, screws, clips, cables, and bone cement, all designed to securely stabilize the sternum, minimize the risk of sternal dehiscence, infection, and mechanical failure, and enhance long-term healing outcomes. Growing preference for rigid sternal fixation, bioresorbable implants, and antimicrobial-coated closure technologies is further transforming post-operative care by lowering infection rates, shortening hospital stays, and improving patient comfort. These innovations are particularly valuable for high-risk patients, including older adults and individuals with obesity or diabetes, who require enhanced chest wall stability after surgery.

As hospitals increasingly prioritize improved surgical outcomes, reduced readmissions, and cost-effective cardiac care, demand for next-generation sternal closure devices and systems is expected to remain strong, making technological innovation and procedural efficiency key factors shaping the future growth of the global sternal closure systems market.

Market Dynamics

Drivers

Technological advancements in sternotomy techniques

Advancements in sternotomy techniques, including rigid plate fixation, titanium-based closure systems, and bio-compatible materials, improve sternal stability, shorten recovery time, reduce complications, and increase surgeon preference for advanced sternal closure devices.

Increasing number of cardiothoracic surgical procedures

The growing incidence of cardiovascular diseases, expanding aging population, and rising volumes of open-heart and thoracic surgeries are increasing demand for reliable sternal closure systems that enhance postoperative healing and patient safety.

Restraint/Challenge

Complications associated with sternal closure

Risks including sternal wound infection, dehiscence, instability, and delayed bone healing may require revision surgeries, limiting clinician confidence and encouraging continuous improvements in sternal closure system performance and safety.

High cost of advanced closure systems

Premium rigid fixation plates and titanium-based closure systems involve higher procurement and procedural costs, restricting adoption in budget-constrained hospitals and emerging healthcare markets despite their long-term clinical benefits.

Sternal Closure Systems Market Trends

The sternal closure systems market is evolving rapidly as healthcare providers prioritize advanced fixation technologies that improve surgical outcomes, accelerate recovery, and reduce postoperative complications following cardiac and thoracic procedures. A key trend shaping the market is the growing adoption of premium biomaterials such as polyether ether ketone (PEEK) and titanium, which offer excellent biocompatibility, superior corrosion resistance, long-term durability, and MRI compatibility, making them preferred choices for modern sternal fixation systems.

At the same time, hospitals are increasingly adopting rigid plate fixation and interlocking sternal closure systems because they provide enhanced chest wall stability, promote faster bone healing, lower the risk of sternal dehiscence and infections, and improve overall patient outcomes compared with conventional wire cerclage techniques. Rising demand for minimally invasive cardiac surgery is further driving innovation, encouraging manufacturers to design sternal closure devices that can be implanted through smaller incisions without compromising fixation strength, thereby shortening hospital stays and enabling faster patient recovery.

Another significant growth trend is the increasing focus on patient-specific sternal closure solutions, where customized implants and fixation systems are developed to match individual anatomical structures and complex surgical requirements. Supported by advances in digital imaging, precision manufacturing, and implant design technologies, these personalized solutions help surgeons achieve a more accurate fit, improve procedural efficiency, and reduce revision rates.

As cardiovascular procedure volumes continue to rise worldwide, ongoing investments in innovative sternal closure technologies, customized implants, and next-generation fixation materials are expected to strengthen market growth while addressing the growing demand for safer, more durable, and clinically effective sternal closure systems.

Sternal Closure Systems Market Analysis

Based on product, the market is bifurcated into closure devices and bone cement. The closure devices segment is further sub-segmented into wires, plates and screws, and clips and straps. The closure devices segment dominated the market with the largest revenue share of 89.8% in 2025.
 

• Constant augmentation in open-heart surgeries like coronary artery bypass grafting and heart valve replacement boosts demand for sternal closure devices.
   
• For example, the National Heart, Lung, and Blood Institute reports that over 2 million people worldwide receive open-heart surgery annually. These procedures require median sternotomy; therefore robust closure systems are essential.
   
• As cardiovascular disease remains the major cause of mortality worldwide, the demand for successful bone fixation after surgery continues to increase, requiring closure devices in recovery from cardiac surgery. This high surgical volume attests to the growing significance of reliable sternal closure systems.
   
• Further, advanced surgical approaches and stiff fixation methods in closures, especially for complicated cases, are highly recommended by numerous cardiac surgery guidelines which further facilitates adoption of closure devices.
   

Based on material, the sternal closure systems market is segmented into stainless steel, titanium, and polyether ether ketone (PEEK). The stainless steel segment dominated the market with the largest revenue of USD 1.47 billion in 2025.
 

• Stainless steel sternal closure systems are a cost-saving alternative to titanium and PEEK-based systems for use in cost-preventive healthcare practice and areas. Stainless steel satisfies the demands of a mechanical strength and hardness required for routine use in surgery without a high price tag.
   
• This blend of price and performance renders stainless steel the first choice in public hospitals and low-to-middle income nations endeavoring to expand access to cardiothoracic surgery.
   
• Moreover, stainless steel closure system material properties make it possible to efficiently sterilize without losing its structural integrity and thus facilitate cost-saving through bulk buying or restricted reuse measures.
   
• Their stability at sterilization temperatures and mechanical stress favors repeated use in some regulatory settings, adding to their cost-effectiveness in high-volume surgical facilities.
   

Based on procedure, the sternal closure systems market is segmented into median sternotomy, hemistemotomy, and bilateral thoracotomy. The median sternotomy segment dominated the market with the largest revenue of USD 1.9 billion in 2025.
 

• Median sternotomy is the standard method of surgery for open-heart surgery, such as coronary artery bypass grafting (CABG), valve replacement, and heart transplant. The widespread surgery technique generates a continuous demand for sternal closure systems.
   
• The rising prevalence of cardiovascular disease worldwide adds to increased volumes of sternotomy procedures, growing the market for specialized closure devices that ensure proper healing and reduce sternal complications.
   
• The growing number of elderly people is also driving the demand of open-heart surgeries. The elderlies are often at greater risk of developing complications from illnesses like osteoporosis and diabetes. The United Nations estimates that by 2050, one in every six individuals worldwide will be older than age 65, compared to one in eleven in 2019.
   
• Furthermore, based on the National Institutes of Health (NIH), roughly 75% of HF admissions are of individuals aged 65 years or older, with over 50% presenting in individuals 75 years or older. This highlights the paramount importance of advanced closure systems specifically for this age group.
   

• Additionally, median sternotomy is ideal for wide range of procedures such as valve repair/replacement, congenital heart defect corrections, and coronary artery bypass grafting, which ensures the dominance of the segment.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the sternal closure systems market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment dominated the market with a share of 89.9% in 2025.
 

• The application of advanced sternal closure systems with antimicrobial coatings, rigid fixation, and improved biocompatibility reduces infection risks. Hospitals increasingly implement these systems to comply with regulatory standards and enhance patient safety indicators, which drives the use of sternal closure systems across these acute care facilities.
   
• In addition, there is greater pressure placed on hospitals to reduce infection rates for invasive surgeries, particularly those high-risk surgeries such as median sternotomy. Surgical site infections (SSIs) result in longer hospital stay, readmission, and treatment costs. As a result, to avoid SSIs, the demand for advanced sternal closure systems is high across hospitals.
   
• The widespread implementation of Enhanced Recovery After Surgery (ERAS) protocols within hospitals aims to improve outcomes from surgery and reduce healthcare expenditure. Sternotomy closure devices that maximize healing velocity, allow for early mobilization, and reduce post-operative complications, adhering to the protocols of value-based care.
   
• These systems also appeal to hospitals by reducing resource utilization, optimizing bed turnovers, and enhancing patient satisfaction scores, that are key elements in value-based care delivery.

North America: The U.S. sternal closure systems market is projected to grow significantly from USD 1.1 billion in 2025 to USD 1.7 billion by 2034.
 

• The U.S. has among the highest cardiovascular disease rates in the world and observes large number of open-heart surgeries yearly. The Centers for Disease Control and Prevention (CDC) reveals that approximately 659,000 individuals in the U.S. perish from heart disease annually, contributing to 1 out of every 4 deaths.
   
• Median sternotomy is needed for surgical procedures like CABG and valve replacement, and therefore, dependable sternal closure systems are necessary for these procedures. These conditions and the aging population further sustain surgical volume and closure system demand among U.S. healthcare institutions. The persistence of such disease burden underscores the imperative for successful sternal closure solutions for cardiosurgical procedures.
   
• The Centers for Medicare & Medicaid Services (CMS) value-based reimbursement model also puts a penalty on hospitals for avoidable readmissions, especially in the case of cardiac surgery. Sternal dehiscence or wound infection are among complications which usually become the cause of costly readmissions.
   
• U.S. hospitals have subsequently adopted advanced sternal closure systems that decrease such complications and enhance recovery outcomes, in keeping with objectives for cost-effective, quality healthcare delivery, driving the revenue growth in the market.
   
• Furthermore, U.S. cardiac surgeons stay well-informed and practice evidence-based medicine, and clinical guidelines recommend sternotomy closure with sternal fixation, especially in high-risk cases which calls for high adoption of sternal closure devices.
   

Europe: The sternal closure systems market in UK is expected to experience significant and promising growth from 2026 to 2034.
 

• The UK's National Health Service (NHS) emphasizes minimizing post-operative complications and inpatient stays length, to optimize hospital resources. The use of sophisticated sternal closure systems, such as rigid fixation devices, facilitates better patient outcomes and early discharge, which drives their adoption in UK.
   
• These products reduce complications like sternal dehiscence and wound infection, allowing hospitals to achieve quality goals while maximizing resource use under NHS cost limits.
   
• Further, with the increasing number of elderly people in the UK, the incidence of heart valve disease, coronary artery disease, and other cardiac diseases amenable to surgery has also risen. For example, as per the House of Commons Library, in 2022, there were 12.7 million individuals aged 65 and above, making up 19% of the population of the UK.
   
• They face increased risk for compromised healing of the bones and surgical complication that requires better stabilization through more complex sternal closing systems. Hence, the above-mentioned factors propels the market growth in the country.
   

Asia Pacific: Japan sternal closure systems market is anticipated to witness lucrative growth between 2026 – 2034.
 

• The aging population in Japan contributes to the largest percentage among developed countries. For example, as per the Japanese Ministry of Health, persons aged 65 years and older comprised about 30% of the total Japanese population in 2023.
   
• The elderly population is most susceptible to cardiovascular diseases, such as aortic stenosis and coronary artery disease, that often necessitate median sternotomy interventions.
   
• Moreover, as per the NIH, cardiovascular diseases are responsible for about 28.2% of all fatalities in Japan. The high risk of sternal complications in elderly patients has led surgeons to implement sophisticated closure systems that ensure better bone fixation and shorter recovery times, thus leading to better patient outcomes among Japan's elderly population.
   

Middle East and Africa: The Saudi Arabia sternal closure systems market is expected to experience significant and promising growth from 2026 to 2034.
 

• Saudi Arabia has high prevalence rates of diabetes, obesity, and hypertension in the Middle East, making it more likely to have cardiovascular diseases needing surgical intervention.
• Saudi Vision 2030 includes large-scale investments in building healthcare infrastructure, including cardiac centers and tertiary-level hospitals. Establishment of new hospitals and modernization of the old ones involve advanced surgical technology like advanced sternal closure systems.
   
• This governmental program to enhance healthcare delivery and clinical outcomes has increased the application of rigid fixation systems and innovative closure techniques in public and private healthcare facilities, driving the revenue growth in the country.
   

Sternal Closure Systems Market Share

The market has a dynamic mix of international and domestic players providing innovative solutions to meet the growing demand for advanced systems for the growing patient population. Companies such as Johnson & Johnson, Zimmer Biomet, KLS Martin, Stryker, and B. Braun are some of the dominant competitors in the market accounting for a combined market share of approximately 65%. Competition in this area arises from continuous technological developments and the ability to offer customized solutions for various sternal closure system applications.
 

In developing nations, due to the priority given to cost, multinational companies are squeezed to offer sternal closure systems that are both affordable and of quality. Domestic manufacturers take advantage of this demand by providing cost effective alternatives, which make multinationals alter their price strategy while maintaining the safety, ruggedness, and regulatory acceptability of the products.

Sternal Closure Systems Market Companies

Some of the eminent market participants operating in the sternal closure systems industry include:

• Able Medical
• Abyrx
• Acumed
• B. Braun
• IDEAR
• Jace Medical
• Jeil Medical
• Johnson & Johnson
• Kinamed
• KLS Martin
• Orthofix
• Praesidia
• Stryker
• Waston Medical
• Zimmer Biomet
   
• Johnson & Johnson has market leadership in sternal closure through its DePuy Synthes business. It offers a complete line of products ranging from stainless steel wires to titanium plates and hybrid systems. Its strong position in the market is backed through established clinical credibility, broad surgical expertise, and world-wide distribution capability targeting high-volume cardiac centers serving.
   
• Zimmer Biomet is committed to individualized solutions, including titanium plates, 3D-printed and low-profile sternal fixation systems for minimal invasive procedures. The products provided by the company offers increased biomechanical stability, which lowers the sternal dehiscence complications, particularly helpful with high-risk candidates like obesity or osteoporosis.
   
• KLS Martin is particularly noted for their rigid fixation systems such as the Modular Sternal Cable System and anatomical locking plates for repeat and complex sternotomies. German ingenuity in the firm couples thin, light forms with structural stiffness and minimizes hardware-caused pain.
   

Sternal Closure Systems Industry News

• In January 2026, Johnson & Johnson reported full-year 2025 sales of USD 94.2 billion, reflecting 6% operational growth, while its MedTech business continued to strengthen its thoracic fixation portfolio through DePuy Synthes' sternal closure solutions. The strong financial performance was expected to support continued investment in surgical fixation technologies and product innovation.
• In October 2025, Johnson & Johnson announced plans to separate its DePuy Synthes orthopaedics business into an independent company. The business generated approximately USD 9.2 billion in annual sales, and the strategic restructuring was expected to enhance operational focus and accelerate innovation across its orthopedic and fixation product portfolio, including sternal closure systems.
   

The sternal closure systems market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

By Product

• Closure devices
  • Wires
  • Plates and screws
  • Clips and straps
• Bone cement

By Material

• Stainless steel
• Titanium
• Polyether ether ketone (PEEK)

By Procedure

• Median sternotomy
• Hemistemotomy
• Bilateral thoracotomy

By End Use

• Hospitals
• Ambulatory surgical centers
• Specialty clinics

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific 
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE